Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

Patients with psoriasis, psoriatic arthritis, and axial spondylarthritis using ixekizumab have a low incidence rate of cerebro-cardiovascular events.

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

Sweden 10 Year Government Bond-0.1810 2.3959% ...

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

This January, Stasher, an innovative brand committed to helping you live life with less plastic through its line of reusable solutions, is offering “Resolution Relief,” a special initiative ...

Background Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic arthritis (PsA). We evaluated upadacitinib in ... corticosteroids (equivalent to ≤10 mg/day ...